Private equity firm PEAL Capital Group has acquired a majority stake in London-based cosmetic training provider Derma Medical.

This is the first deal inked by the firm via its inaugural fund, PEAL Capital Partners ILP, which targets companies valued between $40-200 million in the industrial, business services, consumer services and financial services sectors, across Western Europe, the UK and North America. 

With PEAL Capital’s support, Derma Medical expects to further boost its grow and expand internationally, according to the company.

Founded in 2017, Derma Medical provides non-surgical aesthetic treatment training in London, Birmingham, Manchester, and Edinburgh. The group runs international training academies in Sydney, Brisbane, Melbourne, and Perth in Australia, Stockholm, Sweden and Dubai, UAE.

The firm pointed to the hike in the global facial injectables market which is projected to grow from $4.77 billion in 2021 to $9.07 billion in 2028 at a CAGR of 9.6% in the forecast period 2021-2028, according to Fortune.

Following the deal, Jennifer Fox, who has a background in global hospitality and luxury branding, will join the Derma Medical team as executive chair.

PwC, Silicon Valley Bank, Rosetta Tax, Locke Lord, McCann FitzGerald, Waystone, SEI, Ince, Kroll and RWT Growth advised on this transaction.

Date Published: 23 May 2022

Continue reading

Subscribe to get unlimited digital access.


Already a subscriber? Login